In a recent paper entitled "A genetic-based algorithm for personalized resistance training", Jones et al. [1] proposed an algorithm of 15 performance-associated gene polymorphisms that they assert can determine an athlete's training response by predicting power and endurance potential. Two studies were conducted and involved athletes from several sports (e.g. swimming, ski/snowboard, squash, motorsport, and football players) undergoing an eight-week high-or lowintensity resistance training intervention comprising of one or two training sessions per week; participants continued sport-specific training and competition during the intervention period. The DNAFit Peak Per- [1] presented an algorithm of 15 performance-associated gene polymorphisms that they propose can determine an athlete's training response by predicting power and endurance potential. However, from the design of their studies and the data provided, there is no evidence to support these authors' assertions. Progress towards such a significant development in the field of sport and exercise genomics will require a paradigm shift in line with recent recommendations for international collaborations such as the Athlome Project (see www.athlomeconsortium.org). Large-scale initiatives, involving numerous multi-centre and well-phenotyped exercise training and elite performance cohorts, will be necessary before attempting to derive and replicate training and/or performance algorithms. 
each of the two training groups. On the basis of these results, the authors concluded that the DNAFit Peak Performance Algorithm TM can be used to guide personalised resistance-training prescription.
It is clear from the study design and the data provided by Jones et al. that there is no evidence to support these authors' assertions.
The DNAFit Peak Performance Algorithm TM used by these authors comprises 15 polymorphisms in 14 genes (ACE, ACTN3, ADRB2, AGT, BDKRB2, COL5A1, CRP, GABPB1, IL6, PPARA, PPARGC1A, TRHR, VDR and VEGFA); most of which have been associated, albeit tentatively with sports performance in the literature (see Table 1 and [2] ). To our knowledge, there is no direct evidence linking CRP (rs1205) polymorphism to endurance performance (not included in Table 1 ); this specific polymorphism has recently been linked to a protective effect in the pathogenesis of cardiovascular heart disease in a meta-analysis [3] . Genetic findings to sports performance have been inconclusive to date, by primarily using the candidate gene approach in small sample sizes [4.5] . As presented in Table 1, there are positive and negative findings for some genetic markers but few of these polymorphisms have been replicated. Notably, for the TRHR gene variant, there is only one study supporting the link with lean body mass variation [6, 7] muscle strength in elderly population in three studies but results remain inconclusive [8] . In contrast, ACE I/D and ACTN3 R577X have been extensively studied and replicated to some degree in different populations [9] , these two polymorphisms (together, separately, or part of an algorithm) do not predict training response [2, 10, 11] .
It is widely acknowledged that a single gene or a combination of a few genes (using genotype score) may explain a very low percentage of sports performance variation, for example, a 2-3% of sprinting performance variability may be explained by ACTN3 genotype [11, 12] . Nevertheless, a recent meta-analysis of genome-wide association studies and their replications reported that common genetic variants could not discriminate elite endurance athletes from respective control populations (GENATHLETE, Japan, Australia, Poland, Russia, Spain, Kenya, and Ethiopia) [13] . Therefore, the research evidence to date to support the selection of any polymorphism is weak [11, 14, 15] small sample sizes of 28 and 39 participants, respectively. Although authors stated that the sample sizes used were sufficient after power calculation, details of the power calculation were not provided and is most unlikely given the data presented and on the basis of other studies [19] [20] [21] . Progress towards developing training and/ or performance algorithms will require a paradigm shift in line with recent recommendations for international collaborations [22] such as the Athlome Project (see www.athlomeconsortium.org). Such large-scale initiatives, designed specifically to overcome many of the limitations of small single-site studies will be necessary before attempting to derive and replicate training and performance algorithms.
In conclusion, while it is widely acknowledged that a favourable genotype combined with suitable training will enhance trainability and sporting performance, to date few (i.e. ACTN3 and ACE) polymorphisms have been associated with an acceptable level of replication with endurance or power athletic performance, and none of these associations are strong enough to predict elite sports performance or trainability [14, 23, 24] . Currently, there is lack of scientific evidence supporting the predictive values of genetic tests (direct-to-consumer) for prescription of exercise training programmes, or for that matter, talent identification. Further studies with replication are needed in order for genetic variants to be used in personalised training prescription. As stated by Webborn et al., research findings should not be misinterpreted for commercial purposes [11] .
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